Items where SHU Author is "Reynolds, Gavin"
|Up a level|
Jump to: Article
Number of items: 22.
REYNOLDS, Gavin and NEILL, J. C (2016). Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine. Journal of Psychopharmacology, 30 (11), 1141-1144.
XU, Zhi, REYNOLDS, Gavin P., YUAN, Yonggui, SHI, Yanyan, PU, Mengjia and ZHANG, Zhijun (2016). TPH-2 polymorphisms interact with early life stress to influence response to treatment with antidepressant drugs. International Journal of Neuropsychopharmacology, 19 (11), 1-8.
DING, Kaijing, YANG, Jianzhong, REYNOLDS, Gavin, CHEN, Bing, SHAO, Jingru, LIU, Ruixiang, QIAN, Qiujin, LIU, Hua, YANG, Runxu, WEN, Jianfan and KANG, Chuanyuan (2016). DAT1methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD. The World Journal of Biological Psychiatry, 1-9. (In Press)
FACHIM, Helenne, SRISAWAT, Umarat, DALTON, Caroline, HARTE, Michael K, MARSH, Samuel, NEILL, Joanna C and REYNOLDS, Gavin (2016). Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain. Epigenomics, 8 (9), 1179-1183.
COOPER, S. J., REYNOLDS, Gavin, BARNES, T., ENGLAND, E., HADDAD, P., HEALD, A., HOLT, R., LINGFORD-HUGHES, A., OSBORN, D., MCGOWAN, O., PATEL, M., PATON, C., REID, P., SHIERS, D. and SMITH, J. (2016). BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. Journal of Psychopharmacology, 30 (8), 717-748.
VEERASAKUL, Siriluk, THANOI, Samur, REYNOLDS, Gavin and NUDMAMUD-THANOI, Sutisa (2016). Effect of Methamphetamine Exposure on Expression of Calcium Binding Proteins in Rat Frontal Cortex and Hippocampus. Neurotoxicity Research. (In Press)
MCKIBBEN, C. E., REYNOLDS, G. P. and JENKINS, T. A. (2016). Concurrent risperidone administration attenuates the development of locomotor sensitization following sub-chronic phencyclidine in rats. Pharmacopsychiatry, 49 (02), 62-65.
REYNOLDS, Gavin and FACHIM, Helene A (2016). Does DNA methylation influence the effects of psychiatric drugs? Epigenomics, 8 (3), 309-312.
NAZREE, Nur Elia, MOHAMED, Zahurin, REYNOLDS, Gavin, MOHD ZAIN, Shamsul, MASIRAN, Ruziana, SIDI, Hatta, CHONG, Lu Ann, HWAY, Anne Yee, ADLAN, Aida Syarinaz and ZAINAL, Nor Zuraida (2015). Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder. Asia-Pacific Psychiatry, n/a-n/a.
IAMJAN, Sri-arun, THANOI, Samur, WATIKTINKORN, Paritat, NUDMAMUD-THANOI, Sutisa and REYNOLDS, Gavin (2015). BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. Pharmacogenomics, 16 (14), 1541-1545.
TANG, Hao, DALTON, Caroline, SRISAWAT, Umarat, ZHANG, Zhi Jun and REYNOLDS, Gavin (2014). Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia. The International Journal of Neuropsychopharmacology, 17 (04), 645-649.
REYNOLDS, Gavin P., MCGOWAN, Olga O. and DALTON, Caroline F. (2014). Pharmacogenomics in psychiatry : the relevance of receptor and transporter polymorphisms. British Journal Of Clinical Pharmacology, 77 (4), 654-672.
ROFFEEI, Siti Norsyuhada, MOHAMED, Zahurin, REYNOLDS, Gavin, SAID, Mas Ayu, HATIM, Ahmad, MOHAMED, Elsa Haniffah Mejia, AIDA, Syarinaz Ahmad and ZAINAL, Nor Zuraida (2014). Association of FTO,LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics, 15 (4), 477-485.
MCKIBBEN, C. E., REYNOLDS, Gavin and JENKINS, T. A. (2014). Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat. Journal of Psychopharmacology, 28 (10), 955-963.
LIM, C H, ZAIN, S M, REYNOLDS, Gavin, ZAIN, M A, ROFFEEI, S N, ZAINAL, N Z, KANAGASUNDRAM, S and MOHAMED, Z (2014). Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 54, 157-162.
SRISAWAT, Umarat, REYNOLDS, Gavin P., ZHANG, Zhi Jun, ZHANG, Xiang Rong, ARRANZ, Belen, SAN, Luis and DALTON, Caroline F. (2014). Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia. International Journal of Neuropsychopharmacology, 17 (3), 485-490.
TANG, H, MCGOWAN, O O and REYNOLDS, Gavin (2014). Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action. Pharmacogenomics, 15 (12), 1599-1609.
ROFFEEI, Siti Norsyuhada, REYNOLDS, Gavin P., ZAINAL, Nor Zuraida, SAID, Mas Ayu, HATIM, Ahmad, AIDA, Syarinaz Ahmad and MOHAMED, Zahurin (2013). Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Human Psychopharmacology: Clinical and Experimental, 29 (1), 38-45.
REYNOLDS, Lindsay M. and REYNOLDS, Gavin (2011). Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder. Journal of Psychiatric Research, 45 (1), 54-59.
GLYNN, Dervila, GIBSON, Helen E., HARTE, Michael K., REIM, Kerstin, JONES, Susan, REYNOLDS, Gavin and MORTON, A. Jennifer (2010). Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse. Human Molecular Genetics, 19 (17), 3402-3412.
REYNOLDS, Gavin and KIRK, S.L. (2010). Metabolic side effects of antipsychotic drug treatment : pharmacological mechanisms. Pharmacology and Therapeutics, 125 (1), 169-179.
YEVTUSHEKO, Olga O., COOPER, Stephen J., O'NEILL, Ryan, DOHERTY, Jennifer K., WOODSIDE, Jayne V. and REYNOLDS, Gavin (2008). Influence of 5-HT2c receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. British Journal of Psychiatry, 192 (6), 424-428.